EIR Novartis Pharmaceuticals Feb 2019

Peter Lenahan FDA$595.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals - East Hanover, NJ, United States facility and issued inspectional observation (via FDA 483) on 21 Feb 2019.

Product details

  • Category:
  • Inspection end: 21 Feb 2019
  • Location: East Hanover, United States
  • FEI: 2210396
Add To Cart